JP2023524444A5 - - Google Patents

Info

Publication number
JP2023524444A5
JP2023524444A5 JP2022565803A JP2022565803A JP2023524444A5 JP 2023524444 A5 JP2023524444 A5 JP 2023524444A5 JP 2022565803 A JP2022565803 A JP 2022565803A JP 2022565803 A JP2022565803 A JP 2022565803A JP 2023524444 A5 JP2023524444 A5 JP 2023524444A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
sequence shown
region containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022565803A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524444A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/029560 external-priority patent/WO2021222355A1/en
Publication of JP2023524444A publication Critical patent/JP2023524444A/ja
Publication of JP2023524444A5 publication Critical patent/JP2023524444A5/ja
Priority to JP2025284219A priority Critical patent/JP2026047374A/ja
Pending legal-status Critical Current

Links

JP2022565803A 2020-04-29 2021-04-28 医薬製剤 Pending JP2023524444A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025284219A JP2026047374A (ja) 2020-04-29 2025-12-26 医薬製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063017051P 2020-04-29 2020-04-29
US63/017,051 2020-04-29
PCT/US2021/029560 WO2021222355A1 (en) 2020-04-29 2021-04-28 Pharmaceutical formulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025284219A Division JP2026047374A (ja) 2020-04-29 2025-12-26 医薬製剤

Publications (2)

Publication Number Publication Date
JP2023524444A JP2023524444A (ja) 2023-06-12
JP2023524444A5 true JP2023524444A5 (https=) 2024-03-28

Family

ID=76099009

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022565803A Pending JP2023524444A (ja) 2020-04-29 2021-04-28 医薬製剤
JP2025284219A Pending JP2026047374A (ja) 2020-04-29 2025-12-26 医薬製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025284219A Pending JP2026047374A (ja) 2020-04-29 2025-12-26 医薬製剤

Country Status (9)

Country Link
US (1) US20230167175A1 (https=)
EP (1) EP4142790A1 (https=)
JP (2) JP2023524444A (https=)
KR (1) KR20230004799A (https=)
CN (1) CN115484980A (https=)
AU (1) AU2021263813A1 (https=)
CA (1) CA3173706A1 (https=)
IL (1) IL297080A (https=)
WO (1) WO2021222355A1 (https=)

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
ATE243754T1 (de) 1987-05-21 2003-07-15 Micromet Ag Multifunktionelle proteine mit vorbestimmter zielsetzung
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
CA2409991A1 (en) 2000-05-24 2001-11-29 Imclone Systems Incorporated Bispecific immunoglobulin-like antigen binding proteins and method of production
EP1786918A4 (en) 2004-07-17 2009-02-11 Imclone Systems Inc NEW BISPECIFIC ANTIBODY TETRAVALENT
KR20100052545A (ko) 2007-08-28 2010-05-19 바이오겐 아이덱 엠에이 인코포레이티드 Igf―1r의 다중 에피토프에 결합하는 조성물
WO2009070642A1 (en) * 2007-11-28 2009-06-04 Medimmune, Llc Protein formulation
TW202037609A (zh) * 2012-11-01 2020-10-16 美商艾伯維有限公司 抗-vegf/dll4雙重可變區域免疫球蛋白及其用途
TWI793062B (zh) * 2015-07-31 2023-02-21 德商安美基研究(慕尼黑)公司 Dll3及cd3抗體構築體
DE102016124977B4 (de) 2016-12-20 2021-12-16 Endress+Hauser Flowtec Ag Verfahren zum Betreiben eines magnetisch-induktiven Durchflussmessgeräts und ein solches Durchflussmessgerät
SMT202500367T1 (it) * 2017-02-02 2025-11-10 Amgen Res Munich Gmbh Composizione farmaceutica a basso ph comprendente costrutti di anticorpo che reclutano le cellule t
UY37726A (es) * 2017-05-05 2018-11-30 Amgen Inc Composición farmacéutica que comprende constructos de anticuerpos biespecíficos para almacenamiento y administración mejorados
WO2019020745A1 (en) * 2017-07-28 2019-01-31 F. Hoffmann-La Roche Ag Bispecific antibody formulation
JP2020535181A (ja) * 2017-09-29 2020-12-03 ヤンセン バイオテツク,インコーポレーテツド 低用量抗体組成物を安定化する新規製剤

Similar Documents

Publication Publication Date Title
JP7590125B2 (ja) モノクローナル抗体製剤
US11286294B2 (en) Anti-RSV monoclonal antibody formulation
KR20090021298A (ko) 항-egfr 항체의 동결건조 제제
US6616931B1 (en) Rotavirus vaccine formulations
US12186384B2 (en) Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
US20160375133A1 (en) Methods for producing high concentration lyophilized pharmaceutical formulations
US6403098B1 (en) Rotavirus vaccine formulations
US12251474B2 (en) Process for lyophilized pharmaceutical formulations of a therapeutic protein
JP2013500947A5 (https=)
CN101631563B (zh) 含有流感疫苗的冻干制剂及其制备方法
JP2019509311A5 (https=)
AU739916B2 (en) Rotavirus vaccine formulations
JP2013531679A5 (https=)
JP2023538669A5 (https=)
US20230414760A1 (en) Pharmaceutical formulation
JP2022553058A5 (https=)
JP2024540395A5 (https=)
JP2023524445A5 (https=)
JP2023524444A5 (https=)
CN115721732A (zh) 抗体偶联药物的药物组合物、制剂及其制备方法、用途
JP7630625B2 (ja) 改善された凍結乾燥製剤
JP2023501155A5 (https=)
HK40093820A (zh) 抗rsv单克隆抗体配制品
HK40110786A (zh) 抗rsv单克隆抗体配制品
RU2024137628A (ru) Пероральная жидкая суспензия ингибитора киназы pan-raf